JNJ
Johnson & Johnson
NYQ
$222.89
-0.62
(-0.28%)
Pullback · -1.26σ
Grade C
Quarterly financials
last 7 quarters| Quarter | Revenue | Gross profit | Op income | Net income | Free cash flow | Gross % | Op % | Net % |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $24.06B | $15.96B | $6.39B | $5.24B | $1.47B | 66.3% | 26.6% | 21.8% |
| 2025-12-31 | $24.56B | $16.60B | $5.59B | $5.12B | $5.47B | 67.6% | 22.8% | 20.8% |
| 2025-09-30 | $23.99B | $16.69B | $7.10B | $5.15B | $8.00B | 69.6% | 29.6% | 21.5% |
| 2025-06-30 | $23.74B | $16.11B | $6.71B | $5.54B | $2.48B | 67.9% | 28.3% | 23.3% |
| 2025-03-31 | $21.89B | $14.54B | $6.20B | $11.00B | $3.37B | 66.4% | 28.3% | 50.2% |
| 2024-12-31 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |
| 2024-09-30 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |